The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Identification of Patients Most Likely to Benefit From Implantable Cardioverter-Defibrillator Therapy: The Canadian Implantable Defibrillator Study
Open accessAbstract
Background —Patients with resuscitated ventricular tachyarrhythmias (ventricular tachycardia/ventricular fibrillation) benefit from implantable cardioverter-defibrillators (ICDs) compared with medical therapy. We hypothesized that the patients who benefit most from an ICD are those at greatest risk of death. Methods and Results —In the Canadian Implantable Defibrillator Study (CIDS), 659 patients with resuscitated ventricular tachyarrhythmias were randomly assigned to receive an ICD or amiodarone and were then followed for a mean of 3 years. There were 98 and 83 deaths in the amiodarone and ICD groups, respectively. We used multivariate Cox analysis to assess the impact of baseline parameters on the mortality in the amiodarone group. Reduced left ventricular ejection fraction, advanced age, and poor NYHA status identified high-risk patients ( P =0.0001 to 0.0009). Quartiles of risk were constructed, and the mortality reduction associated with ICD treatment in each quartile was assessed. There was a significant interaction between risk quartile and the ICD treatment effect ( P =0.011). In the highest risk quartile, there was a 50% relative risk reduction (95% CI 21% to 68%) of death in the ICD group, whereas in the 3 lower quartiles, there was no benefit. Patients who are most likely to benefit from an ICD can be identified with a simple risk score (≥2 of the following factors: age ≥70 years, left ventricular ejection fraction ≤35%, and NYHA class III or IV). Thirteen of 15 deaths that were prevented by the ICD occurred in patients with ≥2 risk factors. Conclusions —In CIDS, patients at highest risk of death benefited most from ICD therapy. These can be identified easily on the basis of age, poor ventricular function, and poor functional status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Cited by
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
Connolly, S. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2476 · Cited by 1,126
Self-citationTask Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 903
Goldenberg, I., Vyas, A. K., Hall, W. J., Moss, A. J., Wang, H., He, H., Zareba, W., McNitt, S., & Andrews, M. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.058 · Cited by 532
Implantable Cardioverter–Defibrillators
DiMarco, J. P. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035432 · Cited by 290
Metadata
- Authors
- Sheldon, R., Connolly, S., Krahn, A., Roberts, R., Gent, M., & Gardner, M.
- Venue
- Circulation
- Published
- 2000-04-11
- Volume
- 101
- Issue
- 14
- Pages
- 1660-1664
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2113677775
- Cited by
- 215
- References
- 1
- FWCI
- 20.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Patients Most Likely to Benefit From Implantable Cardioverter-Defibrillator Therapy: The Canadian Implantable Defibrillator Study. https://app.cochat.ai/papers/10.1161/01.cir.101.14.1660
- The paper
- Sheldon, R., Connolly, S., Krahn, A., Roberts, R., Gent, M., & Gardner, M. (2000). Identification of Patients Most Likely to Benefit From Implantable Cardioverter-Defibrillator Therapy: The Canadian Implantable Defibrillator Study. Circulation. https://doi.org/10.1161/01.cir.101.14.1660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.